PRICING AGREEMENT
Exhibit 1.2
Execution Version
January 7, 2020
Xxxxx Fargo Securities, LLC
BofA Securities, Inc.
Xxxxxx Xxxxxxx & Co. LLC
UBS Securities LLC
X.X. Xxxxxx Securities LLC
As Representatives of the several Underwriters
named in Schedule I hereto
Xxxxx Fargo Securities, LLC
000 Xxxxx Xxxxx Xxxxxx
Xxxxxxxxx, XX 00000
c/o BofA Securities, Inc.
Xxx Xxxxxx Xxxx
Xxx Xxxx, XX 00000
c/o Morgan Xxxxxxx & Co. LLC
0000 Xxxxxxxx
Xxx Xxxx, XX 00000
c/o UBS Securities LLC
0000 Xxxxxx xx xxx Xxxxxxxx
Xxx Xxxx, XX 00000
c/o X.X. Xxxxxx Securities LLC
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
Ladies and Gentlemen:
MetLife, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein (this “Agreement”) and in the Underwriting Agreement, dated January 7, 2020 (the “Underwriting Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the total number of Securities specified in Schedule I hereto.
Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Agreement, the Applicable Time, and the Closing Date. Each reference to the Representatives herein and in the
provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The Representatives designated to act on behalf of the Underwriters of the Securities pursuant to the Underwriting Agreement are designated as the “Joint Book-Running Managers” at the end of Schedule II hereto.
Subject to the terms and conditions set forth herein and in the Underwriting Agreement incorporated herein by reference, at the time and at the purchase price to the Underwriters set forth in Schedule III hereto, the Company agrees to issue, sell and deliver to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company the number of Depositary Shares set forth opposite the name of such Underwriter in Schedule I hereto under the caption “Total Number of Depositary Shares.” The date of the issuance, sale and delivery of the Depositary Shares is the “Settlement Date” set forth on Schedule II hereto and such date shall be considered a Closing Date under the Underwriting Agreement.
If the foregoing is in accordance with your understanding, please sign and return to us counterparts hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement between each of the Underwriters and the Company. It is understood that your acceptance of this letter on behalf of each of the Underwriters is or will be pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the Company for examination upon request, but without warranty on the part of the Representatives as to the authority of the signers thereof.
[Signature pages follow]
| Very truly yours, | ||
| METLIFE, INC. | ||
| By: | /s/ Xxxxxx Xxxxxx | |
| Name: | Xxxxxx Xxxxxx | |
| Title: | Executive Vice President and Treasurer |
[Signature page to Depositary Shares Pricing Agreement]
Accepted as of the date hereof
on behalf of each of the Underwriters:
| XXXXX FARGO SECURITIES, LLC | ||
| By: | /s/ Xxxxxxx Xxxxxx | |
| Name: | Xxxxxxx Xxxxxx | |
| Title: | Director |
[Signature page to Depositary Shares Pricing Agreement]
| BofA SECURITIES, INC. | ||
| By: | /s/ Xxxxxxx Xxxxxx | |
| Name: | Xxxxxxx Xxxxxx | |
| Title: | Managing Director |
[Signature page to Depositary Shares Pricing Agreement]
| XXXXXX XXXXXXX & CO. LLC | ||
| By: | /s/ Yurij Slyz | |
| Name: | Yurij Slyz | |
| Title: | Executive Director |
[Signature page to Depositary Shares Pricing Agreement]
| UBS SECURITIES LLC | ||
| By: | /s/ Xxxxx Xxxxxxxx | |
| Name: | Xxxxx Xxxxxxxx | |
| Title: | Executive Director |
| By: | /s/ Xxxxxxxx Xxxxxxxx | |
| Name: | Xxxxxxxx Xxxxxxxx | |
| Title: | Associate Director |
[Signature page to Depositary Shares Pricing Agreement]
| X.X. XXXXXX SECURITIES LLC | ||
| By: | /s/ Xxxxxxx X. Xxxxxxx | |
| Name: | Xxxxxxx X. Xxxxxxx | |
| Title: | Executive Director |
[Signature page to Depositary Shares Pricing Agreement]
SCHEDULE I
| Underwriters |
Total Number of Depositary Shares | |||
| Xxxxx Fargo Securities, LLC |
7,200,000 | |||
| BofA Securities, Inc. |
7,200,000 | |||
| Xxxxxx Xxxxxxx & Co. LLC |
7,200,000 | |||
| UBS Securities LLC |
7,200,000 | |||
| X.X. Xxxxxx Securities LLC |
3,600,000 | |||
| Barclays Capital Inc. |
1,266,667 | |||
| Citigroup Global Markets Inc. |
1,266,667 | |||
| Credit Suisse Securities (USA) LLC |
1,266,667 | |||
| Deutsche Bank Securities Inc. |
1,266,667 | |||
| Xxxxxxx Xxxxx & Co. LLC |
1,266,666 | |||
| HSBC Securities (USA) Inc. |
1,266,666 | |||
|
|
|
|||
| Total |
40,000,000 | |||
Schedule I - 1
SCHEDULE II
Filed pursuant to Rule 433
January 7, 2020
Relating to
Preliminary Prospectus Supplement dated January 7, 2020 to
Prospectus dated November 18, 2019
Registration Statement No. 333-234761
MetLife, Inc.
40,000,000 Depositary Shares,
each representing a 1/1,000th interest in a share of
4.75% Non-Cumulative Preferred Stock, Series F
Final Term Sheet
January 7, 2020
| Issuer: | MetLife, Inc. (“Issuer”) | |
| Securities: | Depositary shares (“Depositary Shares”), each representing a 1/1,000th interest in a share of the Issuer’s 4.75% Non-Cumulative Preferred Stock, Series F (“Series F Preferred Shares”) | |
| Number of Depositary Shares: | 40,000,000 | |
| Over-allotment Option: | None | |
| Liquidation Preference: | $25,000 per Series F Preferred Share (equivalent to $25 per Depositary Share) | |
| Aggregate Liquidation Preference: | $1,000,000,000 | |
| Price to the Public: | $25 per Depositary Share | |
Schedule II - 1
| Gross Underwriting Discount (Retail): | $0.7875 per Depositary Share | |
| Gross Underwriting Discount (Institutional): | $0.2500 per Depositary Share | |
| Proceeds to Issuer Before Expenses: | $973,527,237.50 | |
| Maturity Date: | Perpetual | |
| Pricing Date: | January 7, 2020 | |
| Settlement Date*: | January 15, 2020 (T+6) | |
| Dividend Rate and Dividend Payment Dates: | When, as and if declared by the Issuer’s board of directors or a duly authorized committee thereof, the Issuer will pay dividends on a non-cumulative basis, quarterly in arrears on the 15th day of March, June, September and December of each year, commencing on June 15, 2020, at 4.75% per annum, accruing from, and including, the Settlement Date | |
| Day Count Convention: | 30/360 | |
| Payment Business Days: | New York | |
| Optional Redemption: | Series F Preferred Shares are redeemable, in whole or in part, from time to time, on or after March 15, 2025, at a redemption price equal to $25,000 per Series F Preferred Share (equivalent to $25 per Depositary Share), plus an amount equal to any accrued and unpaid dividends that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date | |
| Redemption after the Occurrence of a Rating Agency Event or Regulatory Capital Event: | Series F Preferred Shares are redeemable, in whole but not in part, at any time prior to March 15, 2025, within 90 days after the occurrence of a “rating agency event” or “regulatory capital event” (as defined in the Preliminary Prospectus), at a redemption price equal to (i) in the case of a rating agency | |
Schedule II - 2
| event, $25,500 per Series F Preferred Share (equivalent to $25.50 per Depositary Share), plus an amount equal to any accrued and unpaid dividends per share that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date or (ii) in the case of a regulatory capital event, $25,000 per Series F Preferred Share (equivalent to $25 per Depositary Share), plus an amount equal to any accrued and unpaid dividends per share that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date. | ||
| Listing: | Application will be made to list Depositary Shares on the New York Stock Exchange under the symbol “MET PRF” | |
| Depositary Shares CUSIP/ISIN: | 00000X000 / US59156R8503 | |
| Joint Book-Running Managers: | Xxxxx Fargo Securities, LLC BofA Securities, Inc. Xxxxxx Xxxxxxx & Co. LLC | |
| Co-Managers: | Barclays Capital Inc. Citigroup Global Markets Inc. Credit Suisse Securities (USA) LLC Deutsche Bank Securities Inc. Xxxxxxx Xxxxx & Co. LLC HSBC Securities (USA) Inc. | |
| * | It is expected that delivery of the Depositary Shares will be made against payment therefor on or about January 15, 2020, which is the sixth business day following the date hereof (such settlement cycle being referred to as ‘‘T+6’’). Pursuant to Rule 15c6-1 under the Exchange Act, trades in the secondary market generally are required to settle in two business days unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Depositary Shares prior to the second business day preceding their date of delivery may be required, by virtue of the fact that the Depositary Shares initially will settle in T+6, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement. Purchasers of the Depositary Shares who wish to trade such Depositary Shares prior to their date of delivery should consult their own advisors. |
Schedule II - 3
The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Xxxxx Fargo Securities, LLC toll-free at (000) 000-0000, BofA Securities, Inc. toll-free at (000) 000-0000, Xxxxxx Xxxxxxx & Co. LLC toll-free at (000) 000-0000, UBS Securities LLC toll-free at (000) 000-0000 or X.X. Xxxxxx Securities LLC collect at (000) 000-0000.
Schedule II - 4
SCHEDULE III
Underwriters’ Purchase Price of Depositary Shares: $24.2125 per Depositary Share for retail orders and $24.7500 per Depositary Share for institutional orders
Closing Date: January 15, 2020
Addresses for Notices, etc. to the Representatives:
Xxxxx Fargo Securities, LLC
000 Xxxxx Xxxxx Xxxxxx
Xxxxxxxxx, XX 00000
c/o BofA Securities, Inc.
Xxx Xxxxxx Xxxx
Xxx Xxxx, XX 00000
c/o Morgan Xxxxxxx & Co. LLC
0000 Xxxxxxxx
Xxx Xxxx, XX 00000
c/o UBS Securities LLC
0000 Xxxxxx xx xxx Xxxxxxxx
Xxx Xxxx, XX 00000
c/o X.X. Xxxxxx Securities LLC
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
c/o Barclays Capital Inc.
000 Xxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
c/o Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
c/o Credit Suisse Securities (USA) LLC
00 Xxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
c/o Deutsche Bank Securities Inc.
00 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
Schedule III - 1
c/o Goldman Xxxxx & Co. LLC
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
c/o HSBC Securities (USA) Inc.
000 Xxxxx Xxxxxx
Xxx Xxxx, XX 00000
Schedule III - 2
